<?xml version="1.0" encoding="UTF-8"?>
<ref id="B184-ijerph-17-05648">
 <label>184.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khan</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Fabbri</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Stewart</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Robinson</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Smyth</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>A systematic review of Anakinra, Tocilizumab, Sarilumab and Siltuximab for coronavirus-related infections</article-title>
  <source>medRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.04.23.20076612</pub-id>
 </element-citation>
</ref>
